Chongqing Pharscin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 54.98%

Chongqing Pharscin Pharmaceutical Co., Ltd. Gross Profit Margin is 54.98% for the year ending December 31, 2023, a -7.34% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 59.34%, a 12.52% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 52.74%, a 9.72% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 48.07%, a -24.34% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 63.53%, a -5.45% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
SV Wall Street
Shenzhen Stock Exchange: 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd.

CEO Ms. Xiaoying Liu
IPO Date Oct. 20, 2017
Location China
Headquarters No. 89, Middle Sec of Huangshan Ave
Employees 1,411
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies
Description

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

StockViz Staff

February 3, 2025

Any question? Send us an email